Liu AL, Xu N, Li AJ. COVID-19 with asthma: A case report. World J Clin Cases 2020; 8(15): 3355-3364 [PMID: 32874993 DOI: 10.12998/wjcc.v8.i15.3355]
Corresponding Author of This Article
Ai-Ling Liu, MD, Attending Doctor, Department of Pulmonary and Critical Care Medicine, Weihai Municipal Hospital, Shandong University, No. 70 Heping Road, Weihai 264200, Shandong Province, China. liuailing0730@163.com
Research Domain of This Article
Infectious Diseases
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Aug 6, 2020; 8(15): 3355-3364 Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3355
COVID-19 with asthma: A case report
Ai-Ling Liu, Ning Xu, Ai-Jun Li
Ai-Ling Liu, Ning Xu, Ai-Jun Li, Department of Pulmonary and Critical Care Medicine, Weihai Municipal Hospital, Shandong University, Weihai 264200, Shandong Province, China
Author contributions: Liu AL conceived the study, participated in its design and draft the manuscript; Xu N collected data; Li AJ helped to draft the manuscript; all authors read and approved the final manuscript.
Informed consent statement: Written informed consent was obtained from the patient for publication of this case report.
Conflict-of-interest statement: The authors declared that they have no conflicts of interest regarding this work.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Ai-Ling Liu, MD, Attending Doctor, Department of Pulmonary and Critical Care Medicine, Weihai Municipal Hospital, Shandong University, No. 70 Heping Road, Weihai 264200, Shandong Province, China. liuailing0730@163.com
Received: April 5, 2020 Peer-review started: April 5, 2020 First decision: April 24, 2020 Revised: May 5, 2020 Accepted: July 15, 2020 Article in press: July 15, 2020 Published online: August 6, 2020 Processing time: 123 Days and 0.5 Hours
Abstract
BACKGROUND
Coronavirus disease 2019 (COVID-19) is a public health emergency of international concern. The global population lacks immunity to COVID-19 and is generally susceptible. Underlying conditions, especially chronic respiratory diseases, may affect progression, treatment and prognosis of COVID-19.
CASE SUMMARY
We report a patient with confirmed COVID-19 combined with asthma. It took 41 d from disease onset to discharge to obtain two negative tests for this coronavirus.
CONCLUSION
This case indicates the dynamic clinical characteristics, laboratory and computed tomography findings and adjustment of treatment, and the possible relationship between glucocorticoid therapy and coronavirus clearance.
Core tip: This is a case of confirmed coronavirus disease 2019 with asthma. We reported the whole course. It took 41 d from disease onset to discharge. This case indicated dynamic clinical characteristics, laboratory findings, computed tomography images and adjustment of treatment and discussed the possible relation between glucocorticoids therapy and virus clearance.
